title: Prolonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy.
authors.forename: Pierre-Jean
authors.initials: PJ
authors.lastname: Saulnier
authors.forename: Florence
authors.initials: F
authors.lastname: Dalbiès
authors.forename: Christian
authors.initials: C
authors.lastname: Berthou
authors.forename: François
authors.initials: F
authors.lastname: Guilhot
authors.forename: Nicolas
authors.initials: N
authors.lastname: Bourmeyster
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Chomel
authors.forename: Ali
authors.initials: A
authors.lastname: Thuran
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction / Q000379:methods
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate